Soluble Siglce-9 was higher in COPD patients and subsequently enhanced neutrophil ROS and chemotaxis toward IL-8 likely via competitively inhibition of ligands binding to Siglec-9. This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.